(firstQuint)Study of High Efficient Killing Cell Therapy for Advanced NSCLC.

 Patients with pathological confirmed non-small cell lung cancer with no standard treatment are enrolled.

 The patients fails in previous at least 2 lines of chemotherapy and 1 line of targeted therapy where applicable.

 This is a prospective exploratory trial.

.

 Study of High Efficient Killing Cell Therapy for Advanced NSCLC@highlight

The purpose of this study to preliminarily evaluate the safety and efficacy of High Efficient Killing Cell Therapy for refractory and advanced non-small cell lung cancer